A FIRST-IN-CLASS CALCIUM CHANNEL INHIBITOR FOR THE TREATMENT OF ADVANCED METASTATIC PROSTATE CANCERS RESISTANT TO NEXT-GENERATION ANTIANDROGEN THERAPY

The University Of Queensland

Investigators